Delivery Order SPE2DB22D3301-SPE2DB25FZ1PC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The $10,641.84 contract has an ultimate completion date of April 29, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $10,916.78, with a completion date of July 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This firm fixed-price delivery order, issued on July 24, 2025, with completion targeted for August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and specifies performance at the...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 delivery order contract is for the supply of the drug product PHESGO 600-600 MG-20,000 UNIT 10ML. The contract is a firm fixed price, Delivery Order type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,159.16 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200 units of the pharmaceutical product PHESGO (600 mg/30,000 unit 15 ml). This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is a Firm Fixed Price Delivery Order for PHESGO 600-600 MG-20,000 UNIT 10ML. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of the product "PHESGO 600-600 MG-20,000 UNIT 10ML." This is a firm fixed-price delivery order contract with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1PCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medical products to support military and federal healthcare systems worldwide. The company's extensive portfolio includes brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains, enabling it to fulfill diverse federal procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/25/25 |